Bayesian Statistics: A Narrative Review on Application in Inflammatory Bowel Diseases

Area of Science:

• Biostatistics
• Gastroenterology
• Clinical Trials

Background:

• Inflammatory bowel diseases (IBD) exhibit significant heterogeneity in clinical presentation and treatment response.
• This heterogeneity complicates clinical trials, potentially masking true treatment effects and impacting decision-making.

Purpose of the Study:

• To review the application and benefits of Bayesian statistics in inflammatory bowel diseases (IBD) clinical research.
• To demonstrate how Bayesian methods can enhance IBD trial design, analysis, and pharmacokinetic modeling.

Main Methods:

• Exploration of Bayesian statistical applications in IBD research, including adaptive trial designs and network meta-analysis.
• Discussion of Bayesian pharmacokinetic modeling for personalized treatment predictions in IBD.
• Inclusion of a guide for non-specialists on interpreting Bayesian statistical methods.

Main Results:

• Bayesian methods enable more insightful analysis and refined clinical trial designs for heterogeneous conditions like IBD.
• Adaptive trials using Bayesian techniques allow dynamic sample size adjustments, optimizing power and resources.
• Network meta-analysis and pharmacokinetic modeling benefit from Bayesian approaches for complex data and inter-patient variability.

Conclusions:

• Bayesian statistics provide a robust framework to overcome challenges posed by IBD heterogeneity in clinical research.
• Implementation of Bayesian methods can lead to more efficient trials, accurate treatment effect estimation, and personalized medicine in IBD.
• This review equips researchers and clinicians with an understanding of Bayesian approaches for advancing IBD care.